Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

433

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Meningococcal Meningitis
Interventions
BIOLOGICAL

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine

Trial Locations (19)

15241

PEAK Research 2859 Washington Rd., Ste. 412B, Upper Saint Clair

16148

Kid's Way Pediatrics 3068 Innovation Way, Hermitage

16505

Children's Health Care 2501 West 12th Street, Erie

18960

Pennridge Pediatric Associates 711 Lawn Avenue, Sellersville

19046

Pediatric Medical Associates 1077 Rydal Road Suite 300, Rydal

19402

Pediatric Medical Associates 160 West Germantown Pike Suite D2, East Norriton

19438

Pennridge Pediatric Associates 270 Main Street, Harleysville

21401

28 Annapolis Pediatrics, 200 Forbes Street, Suite 200, Annapolis

35205

Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615, Birmingham

40004

Kentucky Pediatric/Adult Research 201 South Fifth Street, Suite 102, Bardstown

44121

Senders Pediatrics 2054 South Green Road, Cleveland

60614

Children's Memorial Hospital 2300 Children's Plaza, Box 155, Chicago

90241

Premier Health Research 9317 Firestone Blvd., Downey

90723

Center for Clinical Trials, LLC 16415 S. Colorado Ave., Suite 308, Paramount

Center for Clinical Trials, LLC 16660 Paramount Blvd., Suite 301, Paramount

94115

Kaiser Permanente San Francisco 2200 O'Farrell St., Sixth Floor, San Francisco

94588

Kaiser Permanente Pleasanton 7601 Stoneridge Drive, Second Floor, Pleasanton

94611

Kaiser Permanente Oakland 3505 Broadway, 6th Floor, Room 624, Oakland

95051

Kaiser Permanente Santa Clara 710 Lawrence Expressway, Pediatric Clinic Department, Santa Clara

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Novartis Vaccines

INDUSTRY